Hims & Hers Expands Digital Health Platform with New Services
Hims & Hers Health, Inc. (HIMS) has broadened its digital healthcare platform by introducing new care offerings, including Labs, menopause care, and testosterone therapy. The company has also pursued global acquisitions and formed a partnership with Novo Nordisk to offer GLP-1 medications. These expansions aim to enhance the company's telehealth services and address a wider range of health needs.
Key facts
- Hims & Hers introduced Labs, menopause care, and testosterone therapy.
- The company engaged in global acquisitions.
- A partnership with Novo Nordisk was formed for GLP-1 medications.
- The expansions aim to broaden the digital healthcare platform.
- Hims & Hers is a publicly traded company (HIMS).
- The new offerings address a wider range of health needs.
- The company focuses on telehealth services.
- The announcement was made in a news release.
Entities
Institutions
- Hims & Hers Health, Inc.
- Novo Nordisk
Sources
- Quartz —